全文获取类型
收费全文 | 298310篇 |
免费 | 27646篇 |
国内免费 | 17565篇 |
专业分类
耳鼻咽喉 | 2747篇 |
儿科学 | 3678篇 |
妇产科学 | 5101篇 |
基础医学 | 33710篇 |
口腔科学 | 5747篇 |
临床医学 | 38349篇 |
内科学 | 44513篇 |
皮肤病学 | 3612篇 |
神经病学 | 15209篇 |
特种医学 | 10317篇 |
外国民族医学 | 128篇 |
外科学 | 30510篇 |
综合类 | 47464篇 |
现状与发展 | 54篇 |
一般理论 | 40篇 |
预防医学 | 20956篇 |
眼科学 | 7863篇 |
药学 | 31893篇 |
294篇 | |
中国医学 | 16986篇 |
肿瘤学 | 24350篇 |
出版年
2024年 | 1016篇 |
2023年 | 4432篇 |
2022年 | 11221篇 |
2021年 | 14362篇 |
2020年 | 10848篇 |
2019年 | 9399篇 |
2018年 | 10038篇 |
2017年 | 9290篇 |
2016年 | 8591篇 |
2015年 | 13294篇 |
2014年 | 16534篇 |
2013年 | 16008篇 |
2012年 | 23289篇 |
2011年 | 25137篇 |
2010年 | 16616篇 |
2009年 | 13198篇 |
2008年 | 17157篇 |
2007年 | 16649篇 |
2006年 | 15871篇 |
2005年 | 14972篇 |
2004年 | 10144篇 |
2003年 | 9214篇 |
2002年 | 7642篇 |
2001年 | 6487篇 |
2000年 | 6455篇 |
1999年 | 6325篇 |
1998年 | 3507篇 |
1997年 | 3457篇 |
1996年 | 2696篇 |
1995年 | 2621篇 |
1994年 | 2330篇 |
1993年 | 1374篇 |
1992年 | 2118篇 |
1991年 | 1869篇 |
1990年 | 1532篇 |
1989年 | 1383篇 |
1988年 | 1267篇 |
1987年 | 1048篇 |
1986年 | 804篇 |
1985年 | 667篇 |
1984年 | 370篇 |
1983年 | 326篇 |
1982年 | 186篇 |
1981年 | 213篇 |
1980年 | 144篇 |
1979年 | 243篇 |
1978年 | 161篇 |
1977年 | 132篇 |
1974年 | 138篇 |
1972年 | 106篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
慢性鼻窦炎(CRS)是一种常见的慢性非特异感染性鼻部疾病,病理分型主要分为Th2细胞介导的嗜酸性粒细胞性鼻窦炎(ECRS)和Th1细胞介导的非嗜酸性粒细胞性鼻窦炎(非ECRS)2种表型。欧洲国家CRS患病人群主要表现为ECRS,而随着亚洲国家的急剧工业化发展,其ECRS的比例也在急剧增加。ECRS发病机制复杂,涉及多种免疫细胞和相关因子相互作用。其治疗方法包括抗生素、激素药物治疗及手术治疗等,但仍有部分患者症状难以改善或存在复发的风险。Ⅱ型固有淋巴样细胞(ILC2s)是一种非B、非T的新型淋巴细胞,与Th2免疫应答关系密切。文章就ILC2s在ECRS发病机制中的作用进行综述,以期为ECRS的诊断和治疗提供理论参考。 相似文献
52.
It is hypothesized that persons who use drugs (PWUD) in Vietnam who are also HIV-positive may face additional challenges in psychosocial outcomes, and these challenges may extend to their family members. In this study, we examined depressive symptoms, stigma, social support, and caregiver burden of HIV-positive PWUD and their family members, compared to the outcomes of HIV-negative PWUD and their family members. Baseline, 3-month, and 6-month assessment data were gathered from 83 PWUD and 83 family members recruited from four communes in Phú Th? Province, Vietnam. For PWUD, although we observed a general decline in overall stigma over time for both groups, HIV-positive PWUD consistently reported significantly higher overall stigma for all three periods. Depressive symptoms among family members in both groups declined over time; however, family members of HIV-positive PWUD reported higher depressive symptoms across all three periods. In addition, family members of HIV-positive PWUD reported lower levels of tangible support across all three periods. Caregiver burden among family members of HIV-positive PWUD increased significantly over time, whereas the reported burden among family members of HIV-negative PWUD remained relatively unchanged. The findings highlight the need for future interventions for PWUD and family members, with targeted and culturally specific strategies to focus on the importance of addressing additional stigma experienced by PWUD who are HIV-positive. Such challenges may have direct negative impact on their family members' depressive symptoms, tangible support, and caregiver burden. 相似文献
53.
Peng Cheng Linlin Yang Xiaodan Huang Xuejun Wang Maoqing Gong 《Archiv der Pharmazie》2020,353(4):1900350
Malaria, one of the most striking, re-emerging infectious diseases caused by the genus Plasmodium, places a huge burden on global healthcare systems. A major challenge in the control and eradication of malaria is the continuous emergence of increasingly widespread drug-resistant malaria, creating an urgent need to develop novel antimalarial agents. Chalcone derivatives are ubiquitous in nature and have become indispensable units in medicinal chemistry applications due to their diverse biological profiles. Many chalcone derivatives demonstrate potential in vitro and in vivo antimalarial activity, so chalcone could be a useful template for the development of novel antimalarial agents. This review covers the recent development of chalcone hybrids as antimalarial agents. The critical aspects of the design and structure–activity relationship of these compounds are also discussed. 相似文献
54.
56.
目的:探讨美托洛尔(β1受体阻滞剂)用于老年COPD合并冠心病史治疗的临床疗效。方法:选取2018年6月—2019年6月在我院接受治疗的60岁以上(包括60岁)COPD合并冠心病史老年患者,分为对照组与观察组。对照组给予接受布地奈德福莫特罗粉吸入剂治疗,观察组在使用布地奈德福莫特罗粉吸入剂治疗的基础上口服琥珀酸美托洛尔缓释片治疗,观察对比两组治疗效果。结果:观察组临床治疗效果优于对照组,观察组住院时长以及并发症的发生率低于对照组(P<0.05),差异具有统计学意义。结论:老年COPD合并冠心病史接受美托洛尔治疗,可有效缩短住院时长、用药效果明显、有效提升用药安全性,值得临床推广。 相似文献
57.
58.
Acid-suppressive drugs, including histamine-2 receptor antagonists (H2RAs) and proton pump inhibitors (PPIs), are common medications used for treating upper gastrointestinal tract disorders. However, acid-suppressive drugs have been reported to increase the risk of pneumonia in numerous disease populations. However, the relationship between acid-suppressive drugs and stroke-associated pneumonia (SAP) remains controversial.The purpose of this study was to investigate the association between acid-suppressive drug usage and pneumonia among patients with stroke by using a nationwide data set.A population-based cohort study was conducted using a data set from the Taiwanese National Health Insurance Research Database. Data on patients with new-onset stroke from 2010 to 2011 were collected. Patients with and without acid-suppressive drug usage were followed up to identify the occurrence of any type of pneumonia. We estimated the adjusted hazard ratios (HRs) by using the Cox proportional hazards model.The study cohort comprised 7965 patients with new-onset stroke. The incidence of pneumonia was 6.9% (552/7965) and more than 40% (225/552) of patients developed pneumonia within 3 months after an acute stroke. Acid-suppressive drug usage was an independent risk factor of pneumonia. The adjusted HR for the risk of pneumonia in patients with new-onset stroke using acid-suppressive drugs was 1.44 (95% confidence interval [CI] = 1.18–1.75, P < 0.01). Only PPI usage increased risk of chronic SAP (adjusted HR = 1.46, 95% CI = 1.04–2.05).Acid-suppressive drug usage was associated with a slightly increased risk of SAP. Physicians should exercise caution when prescribing acid-suppressive drugs to patients with stroke, particularly at the chronic stage. 相似文献
59.
60.